Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1213 ARTÍCULOS , VIENDO DEL 406 AL 420

SAR studies on carboxylic acid series M(1) selective positive allosteric modulators (PAMs)

Kuduk SD, Beshore DC.

Curr Top Med Chem. 2014;14(15):1738-54. doi: 10.2174/1568026614666140826120224.

Recent advances in the neuroimmunology of cell-surface CNS autoantibody syndromes, Alzheimer's disease, traumatic brain injury and schizophrenia

Needham E, Zandi MS.

J Neurol. 2014 Oct;261(10):2037-42. doi: 10.1007/s00415-014-7473-x. Epub 2014 Sep 3.

The role of glial cells and the complement system in retinal diseases and Alzheimer's disease: common neural degeneration mechanisms

Harvey H, Durant S.

Exp Brain Res. 2014 Nov;232(11):3363-77. doi: 10.1007/s00221-014-4078-7. Epub 2014 Sep 3.

Impact of Alzheimer's Disease on Caregiver Questionnaire: internal consistency, convergent validity, and test-retest reliability of a new measure for assessing caregiver burden

Cole JC, Ito D, Chen YJ, Cheng R, Bolognese J, Li-McLeod J.

Health Qual Life Outcomes. 2014 Sep 4;12:114. doi: 10.1186/s12955-014-0114-3.

The rare TREM2 R47H variant exerts only a modest effect on Alzheimer disease risk

Hooli BV, Parrado AR, Mullin K, Yip WK, Liu T, Roehr JT, Qiao D, Jessen F, Peters O, Becker T, Ramirez A, Lange C, Bertram L, Tanzi RE.

Neurology. 2014 Oct 7;83(15):1353-8. doi: 10.1212/WNL.0000000000000855. Epub 2014 Sep 3.

Microglia in Alzheimer's disease

Li Y, Tan MS, Jiang T, Tan L.

Biomed Res Int. 2014;2014:437483. doi: 10.1155/2014/437483. Epub 2014 Aug 14.

Breaking peripheral immune tolerance to CNS antigens in neurodegenerative diseases: boosting autoimmunity to fight-off chronic neuroinflammation

Schwartz M, Baruch K.

J Autoimmun. 2014 Nov;54:8-14. doi: 10.1016/j.jaut.2014.08.002. Epub 2014 Sep 8.

Transdermal rivastigmine in the treatment of Alzheimer's disease: current and future directions

Amanatkar HR, Grossberg GT.

Expert Rev Neurother. 2014 Oct;14(10):1119-25. doi: 10.1586/14737175.2014.955852. Epub 2014 Sep 9.

Benzodiazepines and risk of Alzheimer's disease

Yaffe K, Boustani M.

BMJ. 2014 Sep 9;349:g5312. doi: 10.1136/bmj.g5312.

Mechanisms of action of phytochemicals from medicinal herbs in the treatment of Alzheimer's disease

Kim MH, Kim SH, Yang WM.

Planta Med. 2014 Oct;80(15):1249-58. doi: 10.1055/s-0034-1383038. Epub 2014 Sep 11.

Prion-like Mechanisms in Alzheimer's Disease

Yin RH, Tan L, Jiang T, Yu JT.

Curr Alzheimer Res. 2014;11(8):755-64. doi: 10.2174/156720501108140910121425.

Pregnane X Receptor and P-glycoprotein: a connexion for Alzheimer's disease management

Jain S, Rathod V, Prajapati R, Nandekar PP, Sangamwar AT.

Mol Divers. 2014 Nov;18(4):895-909. doi: 10.1007/s11030-014-9550-6. Epub 2014 Sep 12.

Non-invasive brain stimulation of the right inferior frontal gyrus may improve attention in early Alzheimer's disease: a pilot study

Eliasova I, Anderkova L, Marecek R, Rektorova I.

J Neurol Sci. 2014 Nov 15;346(1-2):318-22. doi: 10.1016/j.jns.2014.08.036. Epub 2014 Aug 29.

Genetic heterogeneity in Alzheimer disease and implications for treatment strategies

Ringman JM, Goate A, Masters CL, Cairns NJ, Danek A, Graff-Radford N, Ghetti B, Morris JC; Dominantly Inherited Alzheimer Network.

Curr Neurol Neurosci Rep. 2014 Nov;14(11):499. doi: 10.1007/s11910-014-0499-8.

Big data: could it ever cure Alzheimer's disease?

Husain M.

Brain. 2014 Oct;137(Pt 10):2623-4. doi: 10.1093/brain/awu245.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias